abrdn World Healthcare Fund: Business Overview, Financials & Competitive Analysis
abrdn World Healthcare Fund scores 7/10 on the AskCyborg Cyborg Score (Strong). Differentiated closed-end fund capturing global healthcare innovation and demographic tailwinds through active management and sustainable income distribution. As of May 6, 2026, the fund had NAV of $12.72 with a small 0.63% premium and 40.4 million common shares outstanding with target monthly distributions of $0.1167 per share. In.
What is abrdn World Healthcare Fund's industry? abrdn World Healthcare Fund (aberdeeninvestments.com) operates in Mutual Funds. AskCyborg classifies abrdn World Healthcare Fund under Mutual Funds in its company registry.
abrdn World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by abrdn Inc. that invests in public equity and fixed income markets across the globe, focusing on stocks of companies operating ...
Cyborg Score thesis
Differentiated closed-end fund capturing global healthcare innovation and demographic tailwinds through active management and...
Read the full analyst-debate transcript →Get the Latest abrdn World Healthcare Fund Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report Freeabrdn World Healthcare Fund Overview
Pro stress-test →abrdn World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by abrdn Inc. that invests in public equity and fixed income markets across the globe, focusing on stocks of companies operating in the healthcare sector while primarily investing in corporate debt securities for its fixed income portion. The fund focuses on global healthcare and biotech/pharmaceutical opportunities, aiming to capture long-term secular factors of demographics and innovation that will drive sector growth.
Strategic Profile
Pro stress-test →The fund invests at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industry including equity and debt securities. The fund's investment objective is to seek current income and long-term capital appreciation. The portfolio is focused on innovation-led healthcare opportunities globally while maintaining exposure to select large-cap pharmaceutical companies to balance risk, and adds to companies where value creation is driven by company-specific execution rather than broader market sentiment.
Competitive Landscape
Pro stress-test →abrdn World Healthcare Fund competes with other closed-end healthcare-focused mutual funds including abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), and abrdn Healthcare Opportunities Fund (THQ). It also competes with open-ended healthcare mutual funds and ETFs offered by major asset managers. The fund's differentiation lies in its global diversification focus, active management emphasizing innovation-led companies, and consistent monthly distribution strategy.
Industry Context
abrdn World Healthcare Fund operates in Mutual Funds.
Key facts
Founded: 2015 · Headquarters: Philadelphia, US · Revenue: $120.6M (2024)